V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001600 | 330000906 | 1.74 | 48.6 | Neo-adjuvant (N) | 2013-12-19 | 2014-01-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005342 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001601 | 330000907 | 1.73 | null | Curative (C) | 2017-07-01 | 2017-07-01 | Cisplatin | N | Y | 330005347 | CISPLATIN |
| 330001602 | 330000908 | 1.67 | 67.5 | null | null | 2018-01-15 | Cisplatin 7 day | N | Y | 330005349 | CISPLATIN |
| 330001603 | 330000908 | null | 79.7 | Palliative (P) | 2016-09-20 | 2016-09-24 | Trial Unspecified | N | N | 330005349 | TRIAL |
| 330001604 | 330000908 | 1.62 | 71.5 | Neo-adjuvant (N) | 2013-11-28 | 2013-12-18 | Cisplatin | N | N | 330005349 | CISPLATIN |
| 330001605 | 330000908 | 1.69 | 90 | Curative (C) | 2014-10-08 | 2014-11-04 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330005349 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001606 | 330000909 | 1.8 | null | Curative (C) | 2016-09-01 | 2016-09-27 | Cisplatin 7 day | null | N | 330005359 | CISPLATIN |
| 330001607 | 330000910 | 1.75 | 45.8 | Curative (C) | 2014-03-04 | 2014-03-17 | Cisplatin 7 day | N | N | 330005360 | CISPLATIN |
| 330001608 | 330000911 | 1.86 | 92.1 | Adjuvant (A) | 2016-03-04 | 2016-03-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330005365 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001609 | 330000911 | 1.7 | 37.7 | Curative (C) | 2014-02-28 | 2014-03-23 | Cisplatin | N | Y | 330005365 | CISPLATIN |
| 330001610 | 330000911 | 1.71 | 68.2 | Neo-adjuvant (N) | 2014-02-09 | 2014-03-20 | EW EuroEwing 2012 Arm B VDC | N | N | 330005365 | TRIAL |
| 330001611 | 330000912 | 1.7 | 25.7 | Curative (C) | 2014-10-23 | 2014-11-22 | Cisplatin | N | Y | 330005375 | CISPLATIN |
| 330001612 | 330000913 | 1.71 | 68.2 | Neo-adjuvant (N) | 2017-07-10 | 2017-07-21 | CNS LGG 2004 03 cons vinc + carbo | Y | null | 330005377 | NOT MATCHED |
| 330001613 | 330000913 | 1.5 | 10.75 | Curative (C) | 2015-02-21 | 2015-02-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330005377 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001614 | 330000914 | 1.8 | 22 | Curative (C) | 2018-02-28 | 2018-03-25 | Cisplatin | N | N | 330005393 | CISPLATIN |
| 330001615 | 330000915 | 1.68 | 16.7 | Curative (C) | 2016-03-09 | 2016-03-29 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330005399 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001616 | 330000916 | 0 | 94.6 | Curative (C) | 2017-02-12 | 2017-02-12 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | 330005405 | NOT MATCHED |
| 330001617 | 330000916 | 1.64 | 10.1 | Curative (C) | 2013-07-09 | 2013-07-14 | Cisplatin | N | Y | 330005405 | CISPLATIN |
| 330001618 | 330000917 | 1.62 | 8.95 | Curative (C) | 2013-05-17 | 2013-07-05 | Cisplatin | N | Y | 330005413 | CISPLATIN |
| 330001619 | 330000918 | 1.62 | 53.9 | null | null | 2016-07-07 | Cisplatin | 02 | N | 330005418 | CISPLATIN |
| 330001620 | 330000918 | null | 63.9 | Curative (C) | 2017-11-25 | 2017-12-13 | Cisplatin 7 day | null | Y | 330005418 | CISPLATIN |
| 330001621 | 330000919 | 1.73 | null | Palliative (P) | null | 2018-05-20 | EW EuroEwing 2012 Arm B VDC | Y | N | 330005420 | TRIAL |
| 330001622 | 330000919 | null | 95 | Curative (C) | 2014-05-03 | 2014-06-09 | Cisplatin | N | Y | 330005420 | CISPLATIN |
| 330001623 | 330009523 | 1.8 | null | Curative (C) | null | 2013-07-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005439 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001624 | 330000920 | 0 | 61 | Curative (C) | 2015-05-06 | 2015-05-25 | Trial Unspecified | null | Y | 330005444 | TRIAL |
| 330001625 | 330000921 | 1.61 | 77.6 | null | 2013-04-28 | 2013-05-16 | Cisplatin 7 day | null | N | 330005445 | CISPLATIN |
| 330001626 | 330000922 | 1.8 | null | Neo-adjuvant (N) | 2017-12-11 | 2017-12-24 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005446 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001627 | 330000923 | null | 78.65 | Curative (C) | 2015-09-17 | 2015-09-17 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330005452 | NOT MATCHED |
| 330001628 | 330000923 | null | 90.3 | Curative (C) | 2015-12-20 | 2016-01-20 | CNS Medbl Std Risk Maint Cisplatin | N | Y | 330005452 | CISPLATIN |
| 330001629 | 330000924 | null | null | Neo-adjuvant (N) | null | 2016-06-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005461 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001630 | 330000924 | 1.6 | 63.6 | Curative (C) | 2016-04-30 | 2016-05-05 | Cisplatin 7 day | N | Y | 330005461 | CISPLATIN |
| 330001631 | 330000924 | 1.68 | 71.4 | Curative (C) | 2013-06-12 | 2013-06-12 | ALL Interfant 06 MAE | N | N | 330005461 | NOT MATCHED |
| 330001632 | 330000924 | 1.59 | 5.2 | Curative (C) | 2015-05-22 | 2015-06-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005461 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001633 | 330000925 | 0 | null | Curative (C) | 2016-02-22 | 2016-02-23 | CNS LGG2004 03 vinc + carbo | N | N | 330005478 | NOT MATCHED |
| 330001634 | 330000925 | 0 | 74.6 | Curative (C) | 2014-01-23 | 2014-01-23 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330005478 | NOT MATCHED |
| 330001635 | 330000926 | 1.7 | 19.8 | Neo-adjuvant (N) | null | 2017-02-17 | Cisplatin | null | Y | 330005497 | CISPLATIN |
| 330001636 | 330000926 | 1.22 | null | Curative (C) | null | 2016-08-17 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330005497 | NOT MATCHED |
| 330001637 | 330000927 | null | 77.95 | Curative (C) | 2017-09-22 | 2017-09-30 | STS Rhabdomyosarco RMS 2005 IVADoVV | 2 | N | 330005500 | NOT MATCHED |
| 330001638 | 330000928 | null | 194 | Curative (C) | 2017-07-06 | 2017-07-09 | CNS ATRT VCA Vinc/Dactino/Cyclophos + GCSF | N | N | 330005520 | NOT MATCHED |
| 330001639 | 330000929 | 0.98 | 86.5 | Curative (C) | null | 2018-07-07 | CNS ATRT VCA Vinc/Dactino/Cyclophos + GCSF | N | N | 330005522 | NOT MATCHED |
| 330001640 | 330000929 | 1.58 | 33 | Palliative (P) | 2015-09-26 | 2015-09-26 | Trial Unspecified | Y | N | 330005522 | TRIAL |
| 330001641 | 330000929 | 0 | 64.4 | Curative (C) | 2016-07-07 | 2016-08-14 | Trial Unspecified | Y | N | 330005522 | TRIAL |
| 330001642 | 330000930 | 1.68 | 66.2 | Neo-adjuvant (N) | null | 2013-10-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330005545 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001643 | 330000931 | 1.74 | 79.7 | Curative (C) | 2015-04-16 | 2015-05-02 | Cisplatin 7 day | N | Y | 330005547 | CISPLATIN |
| 330001644 | 330000932 | 1.7 | 20.5 | Neo-adjuvant (N) | null | 2016-04-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330005548 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001645 | 330000933 | 1.8 | 65 | Neo-adjuvant (N) | 2014-08-28 | 2014-09-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330005550 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001646 | 330000934 | 0 | 72 | Curative (C) | 2016-10-03 | 2016-10-04 | LI-1 TRIAL | 01 | N | 330005555 | TRIAL |
| 330001647 | 330000935 | null | 12.3 | Curative (C) | 2016-08-04 | 2016-08-08 | NB HRNBL-1 COJEC Ind COURSE A | 2 | N | 330005557 | NOT MATCHED |
| 330001648 | 330000935 | 1.7 | null | Neo-adjuvant (N) | 2017-11-14 | 2017-11-14 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005557 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001649 | 330000936 | null | 65.6 | Curative (C) | 2015-03-25 | 2015-05-02 | Cisplatin | null | Y | 330005569 | CISPLATIN |